Provided by Tiger Trade Technology Pte. Ltd.

SciSparc Ltd.

6.66
-0.0350-0.52%
Volume:10.97K
Turnover:74.23K
Market Cap:3.82M
PE:-0.07
High:7.04
Open:6.92
Low:6.53
Close:6.70
52wk High:80.10
52wk Low:2.98
Shares:573.24K
Float Shares:485.10K
Volume Ratio:0.16
T/O Rate:2.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-98.0714
EPS(LYR):-98.0714
ROE:-178.39%
ROA:-60.68%
PB:0.90
PE(LYR):-0.07

Loading ...

SciSparc unit NeuroThera closes purchase of 54% stake in CliniQuantum for CAD 9.46 million in shares

Reuters
·
Jun 04

Scisparc: Subsidiary Neurothera Labs Completed Acquisition of Cliniquantum

THOMSON REUTERS
·
Jun 04

SciSparc director Itschak Shrem sells 462 shares for $4,620

Reuters
·
Jun 03

BUZZ-U.S. STOCKS ON THE MOVE-Snowflake, Best Buy, Kohl's

Reuters
·
May 29

Why Is SciSparc Stock Skyrocketing On Thursday?

Benzinga
·
May 29

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM

Reuters
·
May 28

SciSparc unit NeuroThera wins conditional TSX approval for CliniQuantum acquisition update

Reuters
·
May 28

Scisparc: Subsidiary Neurothera Labs Received Conditional Regulatory Approval for Acquisition of Cliniquantum

THOMSON REUTERS
·
May 28

SciSparc regains Nasdaq equity compliance, avoids delisting for now

Reuters
·
May 11

Scisparc FY25 net loss widens 94% to USD 12.18 million

Reuters
·
Apr 30

Scisparc Director Alon Dayan Files Initial Beneficial Ownership Statement

Reuters
·
Mar 24

SciSparc Ltd. CEO and CFO Oz Adler Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Scisparc Ltd. Director Moshe Revach Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

SciSparc Ltd. Director Amitay Weiss Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

Scisparc Ltd. files Form 3 initial beneficial ownership statement for Director Lior Vider

Reuters
·
Mar 19

BRIEF-Scisparc Neurothera Labs- Clearmind Medicine Collaboration Leads To Patent Application For Depression Therapy

Reuters
·
Mar 16

NeuroThera Labs files Hong Kong patent application for MEAI-PEA depression therapy

Reuters
·
Mar 16

Scisparc: Neurothera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy

THOMSON REUTERS
·
Mar 16

Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy

THOMSON REUTERS
·
Mar 13

BUZZ-U.S. STOCKS ON THE MOVE -Natera, Pacira BioSciences, Kezar Life Sciences

Reuters
·
Mar 12